[go: up one dir, main page]

SI1017377T1 - Use of 6, 7-substituted 2-aminotetralines for the treatment of cytokine mediated inflammatory conditions - Google Patents

Use of 6, 7-substituted 2-aminotetralines for the treatment of cytokine mediated inflammatory conditions

Info

Publication number
SI1017377T1
SI1017377T1 SI9830040T SI9830040T SI1017377T1 SI 1017377 T1 SI1017377 T1 SI 1017377T1 SI 9830040 T SI9830040 T SI 9830040T SI 9830040 T SI9830040 T SI 9830040T SI 1017377 T1 SI1017377 T1 SI 1017377T1
Authority
SI
Slovenia
Prior art keywords
aminotetralines
substituted
treatment
inflammatory conditions
mediated inflammatory
Prior art date
Application number
SI9830040T
Other languages
Slovenian (sl)
Inventor
Piero Foresta
Vito Ruggiero
Original Assignee
Sigma-Tau Industrie Farmaceutiche Riunite S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IT97RM000569A external-priority patent/IT1294932B1/en
Application filed by Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. filed Critical Sigma-Tau Industrie Farmaceutiche Riunite S.P.A.
Publication of SI1017377T1 publication Critical patent/SI1017377T1/en

Links

SI9830040T 1997-09-22 1998-09-18 Use of 6, 7-substituted 2-aminotetralines for the treatment of cytokine mediated inflammatory conditions SI1017377T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT97RM000569A IT1294932B1 (en) 1997-09-22 1997-09-22 USE OF SUBSTITUTED 2-AMINOTETHRALINE-6,7 FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS SUITABLE FOR THE TREATMENT OF PATHOLOGIES
EP98946704A EP1017377B1 (en) 1997-09-22 1998-09-18 Use of 6, 7-substituted 2-aminotetralines for the treatment of cytokine mediated inflammatory conditions
PCT/IT1998/000250 WO1999015160A2 (en) 1997-09-22 1998-09-18 Use of 6,7-substituted 2-aminotetralines suitable for preparing pharmaceutical composition for the therapeutic treatment of inflammatory and/or autoimmune pathologies

Publications (1)

Publication Number Publication Date
SI1017377T1 true SI1017377T1 (en) 2002-06-30

Family

ID=26152704

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9830040T SI1017377T1 (en) 1997-09-22 1998-09-18 Use of 6, 7-substituted 2-aminotetralines for the treatment of cytokine mediated inflammatory conditions

Country Status (1)

Country Link
SI (1) SI1017377T1 (en)

Similar Documents

Publication Publication Date Title
ZA983452B (en) Substituted pyrrolopyridines useful in the treatment of inflammatory diseases.
ZA983451B (en) Substituted imidazoles useful in the treatment of inflammatory diseases.
HUP0102295A3 (en) Benzamide derivatives for the treatment of diseases mediated by cytokines
AP9901677A0 (en) Substituted benzopyran derivatives for the treatment of inflammation
HUP0102367A3 (en) Benzamide derivatives for the treatment of diseases mediated by cytokines
HU9702167D0 (en) Ceramic glowplug
IL136110A0 (en) Methods and compositions for the treatment of psoriasis
ZA984174B (en) Novel triptolide derivatives useful in the treatment of autoimmune diseases
PL345769A1 (en) Triazolopyridines for the treatment of thrombosis disorders
HK1022267A1 (en) Use of 1-hydroxy-2-pyridones for the treatment of saborrheic dermatitis
IL133089A0 (en) Novel triptolide derivatives useful in the treatment of autoimmune diseases
HUP9901878A3 (en) Furnace
IL129622A0 (en) Novel CIS-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
IL129624A0 (en) Novel (+)-enantiomers of CIS-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
IL129618A0 (en) Novel CIS-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
SI1017377T1 (en) Use of 6, 7-substituted 2-aminotetralines for the treatment of cytokine mediated inflammatory conditions
ZA977491B (en) Use of polyhydroxycarboxylamides as EP additives.
GB9726223D0 (en) The treatment of materials
IL129626A0 (en) Novel CIS-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
AU8049098A (en) Composition and methods for the treatment of inflammatory diseases
ZA985818B (en) Imidazopyrimidines and imidazopyridines for the treatment of neurological disorders.
PT1011678E (en) Use of mecamylamine for the treatment of nicotine-responsive neuropsychiatric disorders
AU9082698A (en) Treatment of inflammatory conditions
AU1579700A (en) Cytokine combination therapy
WO1999015160A3 (en) Use of 6,7-substituted 2-aminotetralines suitable for preparing pharmaceutical composition for the therapeutic treatment of inflammatory and/or autoimmune pathologies